McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
881.12
-2.59 (-0.29%)
Nov 28, 2025, 1:00 PM EST - Market closed
McKesson Employees
McKesson had 51,000 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
51,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,590,078
Profits / Employee
$79,078
Market Cap
108.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 51,000 | 0 | - |
| Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
| Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
| Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
| Mar 31, 2020 | 80,000 | 0 | - |
| Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
| Mar 31, 2018 | 78,000 | 0 | - |
| Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
| Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
| Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
| Mar 31, 2014 | 42,800 | -700 | -1.61% |
| Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
| Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
| Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
| Mar 31, 2010 | 32,500 | 0 | - |
| Mar 31, 2009 | 32,500 | -400 | -1.22% |
| Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
| Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
| Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
| Mar 31, 2005 | 25,200 | 600 | 2.44% |
| Mar 31, 2004 | 24,600 | 100 | 0.41% |
| Mar 31, 2003 | 24,500 | 500 | 2.08% |
| Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
| Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
| Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
| Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
| Mar 31, 1998 | 13,700 | 400 | 3.01% |
| Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
| Mar 31, 1996 | 11,300 | -900 | -7.38% |
| Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MCK News
- 13 days ago - Our Top 10 High Growth Dividend Stocks - November 2025 - Seeking Alpha
- 18 days ago - McKesson Corporation (MCK) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 23 days ago - McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - McKesson raises annual profit forecast on robust demand for specialty drugs - Reuters
- 23 days ago - McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 4 weeks ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 6 weeks ago - Nike and 3 More Companies Raising the Alarm About Tariff Costs - Barrons
- 6 weeks ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons